The Nordic AML Group (NAMLG) aim to foster excellence in research and clinical care in acute myeloid leukemia (AML) in the Nordic countries, by forming an active network of clinicians and basic and translational scientists with deep interest and experience in the field.
Photo: NASA
The best poster at the NAMLG Meeting 2025 will receive a 750€ prize and official recognition from Acta Oncologica.
[News? Please, let us know via namlgewg@gmail.com.]
The European School of Haematology is looking for 2 Young Scientific Reporters, to cover the 7th International Conference on Acute Myeloid Leukemia “Molecular and Translational: Advances in Biology and Treatment”, October 16-18 in Estoril, Portugal.
Find more info and the application form using this link.
Deadline: 2025-09-08.
Gösta Gahrton and Gunnar Juliusson are the editors of the Swedish-language textbook Blodets sjukdomar, which has just been released in a new, extensively revised and expanded edition. The book reflects the rapid advances in hematology – from molecular diagnostics and clonal hematopoiesis to targeted therapies and cell-based treatments.
All chapters have been thoroughly updated, and several entirely new sections have been added, covering topics such as clonal hematopoiesis, hereditary predisposition, mastocytosis, and advanced cell therapy. The book serves both as a modern introduction for physicians in training and as a practical reference for established specialists wishing to stay current with this fast-moving field.
Now available at studentlitteratur.se.
There was a well-attended NAMLG lunch meetng in Munich 2025-03-17. The meeting started with an update on ongoing NAMLG activities with a focus on the upcoming NAMLG meeting in Bergen.
After remarks from the sponsor, Servier, we had an update on the LD-VenEx study followed by an IIS study proposal.
Results from the Finnish VenEx trial (NCT04267081) have now been published in Blood. You can find the publication by using this link.
[Have an event? Please, let us know via namlgewg@gmail.com.]
The Educational Working Group is planning an "AML Course Day" in conjunction with the Nordic AML Meeting in Bergen 2025. The AML Course Day covers topics such as the current […]
Find out more »It's an open meeting for clinicians and preclinical researchers but meant for those that are actually interested to take part in future Nordic collaborative TP53 related myeloid research. The meeting […]
Find out more »Save the dates for the upcoming Nordic AML Meeting in Bergen, Norway, 2025.
Find out more »Click here to add your own text
